---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-262222"
form_type: "8-K"
ticker: "SHC"
cik: "0001822479"
company_name: "Sotera Health Co"
filed_at: "2024-11-20T23:59:59+00:00"
generated_at: "2026-05-29T22:05:16.467724+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Sotera Health outlines 2025-27 growth plan; warns of 2024 EBITDA risk from USD strength

## Summary
- Targets organic revenue CAGR of 5-7% and adjusted EBITDA CAGR of 5-8% for 2025-2027.
- Aims to expand adjusted EBITDA margins by at least 50 bps and generate cumulative FCF >$500M.
- Sees serviceable addressable market of $18B; highlights strategic positioning and durable customer relationships.
- Notes risk that 2024 Adjusted EBITDA could fall modestly below guidance due to recent USD strengthening.

## SEC filing metadata
- accession: 0001193125-24-262222
- form_type: 8-K
- ticker: SHC
- cik: 0001822479
- company_name: Sotera Health Co
- filed_at: 2024-11-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1822479/000119312524262222/0001193125-24-262222-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1822479/000119312524262222/d874127d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-262222
- JSON: https://secwatch.observer/filing/0001193125-24-262222.json
- Plain text: https://secwatch.observer/filing/0001193125-24-262222.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.